Filing Details

Accession Number:
0000950103-21-005729
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-19 21:53:33
Reporting Period:
2021-04-16
Accepted Time:
2021-04-19 21:53:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1642545 Shockwave Medical Inc. SWAV () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1602773 Dan Puckett C/O Shockwave Medical, Inc.
5403 Betsy Ross Drive
Santa Clara CA 95054
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-16 1,109 $17.00 46,897 No 4 M Direct
Common Stock Disposition 2021-04-16 126 $136.89 46,771 No 4 S Direct
Common Stock Disposition 2021-04-16 583 $138.56 46,188 No 4 S Direct
Common Stock Disposition 2021-04-16 300 $139.30 45,888 No 4 S Direct
Common Stock Disposition 2021-04-16 100 $140.14 45,788 No 4 S Direct
Common Stock Acquisiton 2021-04-19 683 $3.42 46,471 No 4 M Direct
Common Stock Acquisiton 2021-04-19 708 $4.03 47,179 No 4 M Direct
Common Stock Disposition 2021-04-19 396 $135.40 46,783 No 4 S Direct
Common Stock Disposition 2021-04-19 315 $136.41 46,468 No 4 S Direct
Common Stock Disposition 2021-04-19 206 $137.15 46,262 No 4 S Direct
Common Stock Disposition 2021-04-19 300 $139.09 45,962 No 4 S Direct
Common Stock Disposition 2021-04-19 174 $140.16 45,788 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2021-04-16 1,109 $0.00 1,109 $17.00
Common Stock Employee Stock Option (Right to Buy) Disposition 2021-04-19 683 $0.00 683 $3.42
Common Stock Employee Stock Option (Right to Buy) Disposition 2021-04-19 708 $0.00 708 $4.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
38,915 2029-03-06 No 4 M Direct
1,025 2027-08-03 No 4 M Direct
5,066 2028-07-19 No 4 M Direct
Footnotes
  1. All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 8/8/2019.
  2. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $136.73 to $137.51. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  3. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $138.05 to $139.02. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  4. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $139.1318 to $139.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  5. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $140.14 to $140.14. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  6. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $134.88 to $135.85. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  7. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $136.05 to $136.93. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  8. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $137.09 to $137.21. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  9. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $138.85 to $139.53. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  10. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $140.06 to $140.29. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  11. 1/48th of the shares subject to the option shall vest monthly from 3/11/19.
  12. 1/48th of the shares subject to the option shall vest monthly from 7/21/17.
  13. 1/48th of the shares subject to the option shall vest monthly from 7/19/18.